Upon treatment of cancer cells with DNA damage inducing agents (e.g., cisplatin and etoposide), MUC1 promotes transcription of growth arrest genes and suppresses p53-dependent apoptotic genes, thereby promoting the survival of these cells upon exposure to anti-cancer agents [31]. Here, MUC1 is linked to cancer.